BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27445167)

  • 1. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.
    Laurin LP; Gasim AM; Derebail VK; McGregor JG; Kidd JM; Hogan SL; Poulton CJ; Detwiler RK; Jennette JC; Falk RJ; Nachman PH
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1752-1759. PubMed ID: 27445167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal and segmental glomerulosclerosis: does prognosis vary with the variants?
    Swarnalatha G; Ram R; Ismal KM; Vali S; Sahay M; Dakshinamurty KV
    Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):173-81. PubMed ID: 25579744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS.
    Laurin LP; Gasim AM; Poulton CJ; Hogan SL; Jennette JC; Falk RJ; Foster BJ; Nachman PH
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):386-94. PubMed ID: 26912551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of histologic variants in FSGS clinical trial with presenting features and outcomes.
    D'Agati VD; Alster JM; Jennette JC; Thomas DB; Pullman J; Savino DA; Cohen AH; Gipson DS; Gassman JJ; Radeva MK; Moxey-Mims MM; Friedman AL; Kaskel FJ; Trachtman H; Alpers CE; Fogo AB; Greene TH; Nast CC
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):399-406. PubMed ID: 23220425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
    Troost JP; Trachtman H; Spino C; Kaskel FJ; Friedman A; Moxey-Mims MM; Fine RN; Gassman JJ; Kopp JB; Walsh L; Wang R; Gipson DS
    Am J Kidney Dis; 2021 Feb; 77(2):216-225. PubMed ID: 32791086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis.
    Troost JP; Trachtman H; Nachman PH; Kretzler M; Spino C; Komers R; Tuller S; Perumal K; Massengill SF; Kamil ES; Oh G; Selewski DT; Gipson P; Gipson DS
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):414-421. PubMed ID: 29167190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of collapsing focal segmental glomerulosclerosis.
    Raja R; Nada R; Yadav AK; Kumar A; Goyal A; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
    Ren Fail; 2016 Jul; 38(6):894-8. PubMed ID: 27266801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
    Cheng P; Xie Q; Liu S; Liu X; Wang L; Hao CM
    Rev Assoc Med Bras (1992); 2024; 70(4):e20230871. PubMed ID: 38716932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.
    He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM
    BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
    Chun MJ; Korbet SM; Schwartz MM; Lewis EJ
    J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.
    Markowitz GS; Nasr SH; Stokes MB; D'Agati VD
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):607-15. PubMed ID: 20203164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary FSGS in Nephrotic Adults: Clinical Profile, Response to Immunosuppression and Outcome.
    Bagchi S; Agarwal S; Kalaivani M; Bhowmik D; Singh G; Mahajan S; Dinda A
    Nephron; 2016; 132(2):81-5. PubMed ID: 26799973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
    Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential risk of remission and ESRD in childhood FSGS.
    Gipson DS; Chin H; Presler TP; Jennette C; Ferris ME; Massengill S; Gibson K; Thomas DB
    Pediatr Nephrol; 2006 Mar; 21(3):344-9. PubMed ID: 16395603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete Remission in the Nephrotic Syndrome Study Network.
    Gipson DS; Troost JP; Lafayette RA; Hladunewich MA; Trachtman H; Gadegbeku CA; Sedor JR; Holzman LB; Moxey-Mims MM; Perumal K; Kaskel FJ; Nelson PJ; Tuttle KR; Bagnasco SM; Hogan MC; Dell KM; Appel GB; Lieske JC; Ilori TO; Sethna CB; Fervenza FC; Hogan SL; Nachman PH; Rosenberg AZ; Greenbaum LA; Meyers KE; Hewitt SM; Choi MJ; Kopp JB; Zhdanova O; Hodgin JB; Johnstone DB; Adler SG; Avila-Casado C; Neu AM; Hingorani SR; Lemley KV; Nast CC; Brady TM; Barisoni-Thomas L; Fornoni A; Jennette JC; Cattran DC; Palmer MB; Gibson KL; Reich HN; Mokrzycki MH; Sambandam KK; Zilleruelo GE; Licht C; Sampson MG; Song P; Mariani LH; Kretzler M
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):81-9. PubMed ID: 26656320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis.
    Zhang YM; Gu QH; Huang J; Qu Z; Wang X; Meng LQ; Wang F; Liu G; Cui Z; Zhao MH
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1582-1589. PubMed ID: 27340287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O; Watier L; Rossert J; Stengel B;
    QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal segmental glomerulosclerosis histologic variants and renal outcomes based on nephrotic syndrome, immunosuppression and proteinuria remission.
    Kawaguchi T; Imasawa T; Kadomura M; Kitamura H; Maruyama S; Ozeki T; Katafuchi R; Oka K; Isaka Y; Yokoyama H; Sugiyama H; Sato H
    Nephrol Dial Transplant; 2022 Aug; 37(9):1679-1690. PubMed ID: 34499164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.